Business & Finance News
Lilly to buy Loxo Oncology for about $8 billion in cancer bet
Eli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations.
